Type 2 Diabetes

Ask the Experts: Dr Baker on SGLT2 Inhibitors

Dr Baker from the Weill Cornell Medicine in New York City talks about SGLT2 inhibitors in the treatment of type 2 diabetes.

Addressing Psychological Insulin Resistance in Patients With Diabetes

Learn about strategies to reduce a patient's reluctance to initiate insulin therapy, a phenomenon called psychological insulin resistance.

Bariatric Surgery: An Effective Treatment for Type 2 Diabetes

Bariatric surgery appears to induce changes in the gastrointestinal tract and its interactions with the endocrine system in ways that may influence glycemic control.

Managing Type 2 Diabetes: The Impact of Secure Patient-Provider Messaging

Secure messaging presents an opportunity for patients and healthcare providers to collaborate on self-management issues like glycemic control, diet, and exercise.

In-Hospital Tramadol Use Increases Hypoglycemia Risk in T1D, T2D

Results indicate that blood glucose monitoring should be conducted in hospitalized patients with diabetes.

Poorly Controlled Rheumatoid Arthritis Increases T2D Risk

Type 2 diabetes is significantly underdiagnosed and undertreated in patients with rheumatoid arthritis.

Type 2 Diabetes and Antidepressant Drug Use: Is There a Causal Link?

Updated meta-analysis confirms the association between antidepressant drug (AD) use and incident diabetes. Future studies should be aimed at evaluating the effect of single AD ...

Video

Latest Headlines

T2D May Play a Protective Role Against Developing Aortic Diseases

T2D May Play a Protective Role Against Developing Aortic Diseases

The novel findings in this study suggest that patients with type 2 diabetes have a significantly reduced risk for short-term mortality after hospitalization for aortic aneurysm compared with population-based control subjects.

Reducing Eating Speed May Prevent Obesity in Type 2 Diabetes

Reducing Eating Speed May Prevent Obesity in Type 2 Diabetes

Eating speed can affect changes in obesity, body mass index, and waist circumference in patients with type 2 diabetes.

Diabetes Mortality Trends in Adults With Low eGFR, No Albuminuria

Diabetes Mortality Trends in Adults With Low eGFR, No Albuminuria

A recent study examined mortality trends in adults with diabetes and assessed albumin-to-creatinine ratios and estimated glomerular filtration rates.

Risk Factors for Diabetes May Be Identified 20 Years Before Diagnosis

Risk Factors for Diabetes May Be Identified 20 Years Before Diagnosis

Risk of developing type 2 diabetes is associated with subtle elevations of glucose and lipids more than 20 years before diagnosis.

Physician-Patient Communication Key for Improving Diabetes Care

Physician-Patient Communication Key for Improving Diabetes Care

Diabetes care can be improved with enhanced communication between providers and patients and improved communication between members of the primary care team.

Metformin Safe in T2D With Moderate to Severe Chronic Kidney Disease

Metformin Safe in T2D With Moderate to Severe Chronic Kidney Disease

This is the first study to have validated a metformin dose adjustment as a function of the estimated glomerular filtration rate in patients with type 2 diabetes and chronic kidney disease.

Increased Risk for Severe Hypoglycemic Events Associated With CV Outcomes

Increased Risk for Severe Hypoglycemic Events Associated With CV Outcomes

The bidirectional relationship between severe hypoglycemic events and cardiovascular outcomes suggests that there may be a common "frail" type 2 diabetes phenotype of patients who are susceptible to both of these events.

Women With T1D, T2D Receiving Increased Intervention in Pregnancy

Women With T1D, T2D Receiving Increased Intervention in Pregnancy

Higher rates of operative delivery and falling gestational age at delivery suggest that this is either reflected by, or despite, increasing obstetric intervention.

Two New Diabetes Medications Now Available

Two New Diabetes Medications Now Available

Two recently-approved diabetes treatments, a semaglutide injection and an insuline aspart injection, are now available in pharmacies across the United States.

Safety, Efficacy of Semaglutide for Inadequately Controlled T2D

Safety, Efficacy of Semaglutide for Inadequately Controlled T2D

Patients with type 2 diabetes who received once-weekly semaglutide had statistically greater reductions in HbA1c and body weight compared with those treated with dulaglutide.

Sign Up for Free e-Newsletters

CME Focus